Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Testosterone affects hair loss, acne, and excessive hair growth, and antiandrogens can help treat these conditions.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Skin creams that block male hormones may help with hair growth, hair loss, and acne.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Type 2 5α-reductase plays a key role in hair loss.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.